ArticleCureus2022
Catheter-Directed Vegetation Aspiration in Tricuspid Valve Bacterial Endocarditis: A Potential Treatment for Poor Surgical Candidates.
Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 6 citations in OpenAlex.
- Tricuspid Valve Endocarditis Beyond the Usual Suspects in a Hemodialysis Patient: A Case Report.Cureus · 2026Article
- Percutaneous Vegetation Debulking Without Lead Extraction in Enterococcal Endocarditis Related to Cardiac Implantable Electronic Device.JACC. Case reports · 2025Article
- Percutaneous thrombectomy assisted lead extraction: successful diagnosis and treatment in a case report of culture negative endocarditis.European heart journal. Case reports · 2025Article
- From flank pain to splenic abscess: a complex case of infective endocarditis with literature review.BMC cardiovascular disorders · 2024Review
- Endovascular aspiration of native tricuspid valve vegetation using INARI catheter in a patient with methicillin-sensitiveRadiology case reports · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Infective endocarditis is a condition that has the potential to cause significant morbidity and mortality. Potential complications include sepsis, heart failure, atrioventricular block, embolic stroke, septic emboli, and intracardiac abscess formation. The backbone of treatment is intravenous antibiotics; however, in certain clinical scenarios, surgical management is also indicated to reduce complications and mortality. There exists a challenging subset of patients who require surgery but carry a high perioperative mortality risk. Percutaneous management of endocarditis is emerging as a potential treatment for this high-risk group of patients: it allows for an attempt at source control while avoiding the high risks of surgery. Herein, we present the case of a 35-year-old male presenting with hemoptysis secondary to pulmonary septic emboli in the setting of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.